HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Severe Refractory Anemia in Primary Intestinal Lymphangiectasia. A Case Report.

AbstractBACKGROUND:
Primary intestinal lymphangiectasia (Waldmann's disease) is a rare disease characterized by dilated lymphatics in the small bowel leading to an exudative enteropathy with lymphopenia, hypoalbuminemia and hypogammaglobulinemia.
CASE PRESENTATION:
We report the case of a 23 year-old male who presented with chronic anemia and in whom primary intestinal lymphangiectasia was diagnosed. A low-fat diet along with nutritional therapy with medium-chain triglyceride supplementation improved the protein-losing enteropathy, but did not solve the anemia. Octreotide was also unsuccessful, and after attempting angiographic embolization therapy, limited small bowel resection together with antiplasmin therapy managed to correct the anemia and control the exudative enteropathy.
CONCLUSIONS:
Although primary intestinal lymphangiectasia is usually adequately managed by nutritional therapy, complications such as anemia can occur and can prove to be a therapeutic challenge.
AuthorsVasile Daniel Balaban, Alina Popp, Mugur Grasu, Florina Vasilescu, Mariana Jinga
JournalJournal of gastrointestinal and liver diseases : JGLD (J Gastrointestin Liver Dis) Vol. 24 Issue 3 Pg. 369-73 (Sep 2015) ISSN: 1842-1121 [Electronic] Romania
PMID26405709 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antifibrinolytic Agents
  • Triglycerides
  • Octreotide
Topics
  • Anemia (blood, diagnosis, etiology, therapy)
  • Antifibrinolytic Agents (therapeutic use)
  • Biopsy
  • Chronic Disease
  • Diet, Fat-Restricted
  • Dietary Supplements
  • Digestive System Surgical Procedures
  • Embolization, Therapeutic
  • Endoscopy, Gastrointestinal
  • Humans
  • Lymphangiectasis, Intestinal (complications, diagnosis, therapy)
  • Lymphedema (complications, diagnosis, therapy)
  • Male
  • Octreotide (therapeutic use)
  • Protein-Losing Enteropathies (etiology, therapy)
  • Severity of Illness Index
  • Treatment Outcome
  • Triglycerides (administration & dosage)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: